FASgen Diagnostics

In 2000, FASgen was established to develop therapeutic applications for cancer, infectious diseases, and metabolic disorders such as obesity and diabetes. In 2001, its subsidiary, FASgen Diagnostics, LLC, was founded to develop potential diagnostic products.